Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)
暂无分享,去创建一个
J. del Valle | M. Pallàs | I. Ferrer | A. Camins | A. Canudas | P. Andrés‐Benito | C. Griñán-Ferré | D. Porquet
[1] D. Butterfield,et al. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. , 2014, Biochimica et Biophysica Acta.
[2] G. Perry,et al. Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.
[3] P. Maher,et al. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice , 2013, Aging cell.
[4] Xiang Gao,et al. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background , 2013, Neuroscience Letters.
[5] N. He,et al. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease , 2013, Journal of the Neurological Sciences.
[6] M. Wolfe. Toward the structure of presenilin/γ-secretase and presenilin homologs. , 2013, Biochimica et biophysica acta.
[7] Yueming Li,et al. Modeling Alzheimer’s Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of Aβ and Tau , 2013, PloS one.
[8] R. Hortigüela,et al. Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice , 2013, Neurobiology of Aging.
[9] S. DeKosky,et al. Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. , 2013, Annual review of medicine.
[10] I. Ferrer,et al. Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease , 2012, Brain pathology.
[11] Xiaochuan Wang,et al. Antioxidant Therapies for Alzheimer's Disease , 2012, Oxidative medicine and cellular longevity.
[12] G. Ricevuti,et al. Mitochondrial Alterations, Oxidative Stress and Neuroinflammation in Alzheimer's Disease , 2012, International journal of immunopathology and pharmacology.
[13] J. Morley,et al. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. , 2012, Current pharmaceutical design.
[14] M. Antunes,et al. The novel object recognition memory: neurobiology, test procedure, and its modifications , 2011, Cognitive Processing.
[15] J. del Valle,et al. Cerebral Amyloid Angiopathy, Blood-Brain Barrier Disruption and Amyloid Accumulation in SAMP8 Mice , 2011, Neurodegenerative Diseases.
[16] Xulun Zhang,et al. Activation and intrinsic γ-secretase activity of presenilin 1 , 2010, Proceedings of the National Academy of Sciences.
[17] B. S. Manjunath,et al. Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice , 2010, The Journal of Neuroscience.
[18] C. Haass,et al. Three-Amino Acid Spacing of Presenilin Endoproteolysis Suggests a General Stepwise Cleavage of γ-Secretase-Mediated Intramembrane Proteolysis , 2010, The Journal of Neuroscience.
[19] S. Pimplikar,et al. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.
[20] W. Banks,et al. Increase in Presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing , 2009, Journal of Experimental Biology.
[21] T. Takeda. Senescence-Accelerated Mouse (SAM) with Special References to Neurodegeneration Models, SAMP8 and SAMP10 Mice , 2009, Neurochemical Research.
[22] P. Wong,et al. Glu332 in the Nicastrin Ectodomain Is Essential for γ-Secretase Complex Maturation but Not for Its Activity* , 2008, Journal of Biological Chemistry.
[23] M. Kritzer,et al. Effects of gonadectomy and hormone replacement on a spontaneous novel object recognition task in adult male rats , 2008, Hormones and Behavior.
[24] George Perry,et al. Alzheimer disease, the two-hit hypothesis: an update. , 2007, Biochimica et biophysica acta.
[25] I. Grundke‐Iqbal,et al. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention , 2007, Journal of cellular and molecular medicine.
[26] Bengt Winblad,et al. Of mice and men: more neurobiology in dementia , 2006, Current opinion in psychiatry.
[27] M. Pallàs,et al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM) , 2005, Mechanisms of Ageing and Development.
[28] D. Butterfield,et al. The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease , 2005, Experimental Gerontology.
[29] Clay W Scott,et al. Mechanism of γ-secretase cleavage activation: Is γ-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop? , 2004 .
[30] Xiongwei Zhu,et al. Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.
[31] M N Rossor,et al. The prevalence and causes of dementia in people under the age of 65 years , 2003, Journal of neurology, neurosurgery, and psychiatry.
[32] A. Agarwal,et al. Role of reactive oxygen species in the pathophysiology of human reproduction. , 2003, Fertility and sterility.
[33] J. Morley,et al. Antibody to Amyloid β Protein Alleviates Impaired Acquisition, Retention, and Memory Processing in SAMP8 Mice , 2002, Neurobiology of Learning and Memory.
[34] P. Pietrini,et al. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. , 2001, Brain : a journal of neurology.
[35] René Hen,et al. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .
[36] J. Morley,et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory , 2000, Peptides.
[37] I. Tesseur,et al. Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice , 2000, Experimental Gerontology.
[38] Min Xu,et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.
[39] G. Perry,et al. How important is oxidative damage? Lessons from Alzheimer's disease. , 2000, Free radical biology & medicine.
[40] B. Dubois,et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.
[41] D. Dickson,et al. Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes , 1999, Neurobiology of Disease.
[42] D. Ingram,et al. Behavioral Assessment of the Senescence-accelerated Mouse (SAM P8 and R1) , 1998, Physiology & Behavior.
[43] M. Enserink. First Alzheimer's Diagnosis Confirmed , 1998, Science.
[44] J. Morley,et al. Learning and memory in the SAMP8 mouse , 1997, Neuroscience & Biobehavioral Reviews.
[45] L. Bahrick,et al. The effect of retrieval cues on visual preferences and memory in infancy: evidence for a four-phase attention function. , 1997, Journal of experimental child psychology.
[46] B. Hyman,et al. Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.
[47] Allan I. Levey,et al. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.
[48] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[49] D. Borchelt,et al. Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo , 1996, Neuron.
[50] J. Wegiel,et al. Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.
[51] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[52] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[53] R. Itzhaki. Possible factors in the etiology of Alzheimer's disease , 1994, Molecular Neurobiology.
[54] A. Nagaoka,et al. Senescence-accelerated mouse (SAM): Age-related reduced anxiety-like behavior in the SAM-P/8 strain , 1992, Physiology & Behavior.
[55] K. Jellinger,et al. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.
[56] Ichiro Akiguchi,et al. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory , 1988, Brain Research.
[57] A. Nagaoka,et al. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM) , 1986, Physiology & Behavior.
[58] G. Glenner,et al. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.
[59] Keiichi Higuchi,et al. A new murine model of accelerated senescence , 1981, Mechanisms of Ageing and Development.
[60] Hyoung-Gon Lee,et al. Neuronal cell cycle re-entry markers are altered in the senescence accelerated mouse P8 (SAMP8). , 2012, Journal of Alzheimer's disease : JAD.
[61] J. del Valle,et al. Characterization of amyloid-β granules in the hippocampus of SAMP8 mice. , 2011, Journal of Alzheimer's Disease.
[62] G. Casadesus,et al. Early amyloid accumulation in the hippocampus of SAMP8 mice. , 2010, Journal of Alzheimer's disease : JAD.
[63] Wiesje M van der Flier,et al. Early-versus late-onset Alzheimer's disease: more than age alone. , 2010, Journal of Alzheimer's disease : JAD.
[64] G. Perry,et al. From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). , 2008, Journal of Alzheimer's disease : JAD.
[65] Manuel Buttini,et al. Mice as models: transgenic approaches and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[66] Apoorva Mandavilli,et al. Of mice and men , 2006, Nature Medicine.
[67] Clay W Scott,et al. Mechanism of gamma-secretase cleavage activation: is gamma-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop? , 2004, Biochemistry.
[68] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[69] X. Gironés,et al. Actualización sobre la patología de la enfermedad de Alzheimer , 2002 .
[70] R. Hen,et al. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.
[71] N. Tumosa,et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. , 2000, Peptides.
[72] A. Nadin,et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. , 2000, Nature.
[73] M. Hosokawa,et al. Senescence-accelerated mouse. , 1999, Methods in enzymology.
[74] H. Braak,et al. Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.